{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:59:35Z","timestamp":1773849575413,"version":"3.50.1"},"reference-count":47,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20187252","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:28:49Z","timestamp":1535452129000},"page":"686-695","source":"Crossref","is-referenced-by-count":19,"title":["Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis"],"prefix":"10.1590","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-2439","authenticated-orcid":false,"given":"Milton","family":"Rodriguez-Zuniga","sequence":"first","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos,  Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-6426","authenticated-orcid":false,"given":"Natalie","family":"Torres","sequence":"additional","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos,  Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-8261","authenticated-orcid":false,"given":"Herney","family":"Garcia-Perdomo","sequence":"additional","affiliation":[{"name":"Universidad del Valle,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0190-9622(86)70151-5","article-title":"Pityriasis rosea update: 1986","volume":"15","author":"Parsons JM","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000445375","article-title":"Pityriasis rosea: a comprehensive classification","volume":"232","author":"Drago F","year":"2016","journal-title":"Dermatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15569527.2016.1225217","article-title":"Atypical pityriasis rosea: clinical evaluation of 27 patients","volume":"36","author":"Kilinc F","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2008.07.045","article-title":"Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology","volume":"61","author":"Drago F","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1468-3083.2008.02939.x","article-title":"The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea","volume":"23","author":"Canpolat Kirac B","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.185699","article-title":"Pityriasis Rosea: An update on etiopathogenesis and management of difficult aspects","volume":"61","author":"Mahajan K","year":"2016","journal-title":"Indian J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000245991","article-title":"Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin","volume":"195","author":"Drago F","year":"1997","journal-title":"Dermatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S0950268804002304","article-title":"Pityriasis rosea--evidence for and against an infectious aetiology","volume":"132","author":"Chuh A","year":"2004","journal-title":"Epidemiol Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jdv.13826","article-title":"A position statement on the management of patients with pityriasis rosea","volume":"30","author":"Chuh A","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2005.06.042","article-title":"Use of high-dose acyclovir in pityriasis rosea","volume":"54","author":"Drago F","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/2229-5178.190515","article-title":"Is a treatment for pityriasis rosea really needed?","volume":"7","author":"Ciccarese G","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"ref12","series-title":"Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration","author":"Higgins J","year":"2011"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher D","year":"2009","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1073\/pnas.87.2.748","article-title":"Isolation of a new herpesvirus from human CD4+ T cells","volume":"87","author":"Frenkel N","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"ref16","first-page":"285","article-title":"[New human herpesvirus, human herpes virus-6]","volume":"47","author":"Yamanishi K","year":"1989","journal-title":"Nihon Rinsho"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005068.pub2","article-title":"Interventions for pityriasis rosea","author":"Chuh AA","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian R","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/2229-5178.156389","article-title":"Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability","volume":"6","author":"Das A","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1468-3083.2010.03676.x","article-title":"Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients","volume":"25","author":"Rassai S","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","article-title":"The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea","volume":"55","author":"Ehsani A","year":"2010","journal-title":"Indian J Dermatol"},{"key":"ref23","first-page":"YC01","article-title":"A randomized, double-blind, placebo-controlled study of efficacy of oral acyclovir in the treatment of pityriasis rosea","volume":"8","author":"Ganguly S","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"ref24","first-page":"57","article-title":"Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of pityriasis rosea","volume":"10","author":"Amatya A","year":"2012","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/0378-6323.182791","article-title":"Acyclovir is not effective in pityriasis rosea: results of a randomized, triple-blind, placebo-controlled trial","volume":"82","author":"Singh S","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jdv.12701","article-title":"Pityriasis rosea of Gibert: immunological aspects","volume":"29","author":"Guarneri F","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0781.2004.00072.x","article-title":"Narrow band UVB phototherapy and oral acyclovir for pityriasis rosea","volume":"20","author":"Chuh A","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2002.00200.x","article-title":"Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6","volume":"119","author":"Watanabe T","year":"2002","journal-title":"J Invest Dermatol"},{"key":"ref29","first-page":"3","article-title":"A clinicohistopathologic study of a randomized double-blind clinical trial using oral dexchlorpheniramine 4 mg, betamethasone 500 mcg and betamethasone 250 mcg with dexchlorpheniramine 2 mg in the treatment of pityriasis rosea: a preliminary report","volume":"5","author":"Lazaro-Medina A","year":"1996","journal-title":"Journal of the Philippine Dermatological Society"},{"key":"ref30","first-page":"87","article-title":"Pityriasis rosea","volume":"69","author":"Stulberg DL","year":"2004","journal-title":"Am Fam Physician"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2013.01.011","article-title":"Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies","volume":"31","author":"Gambichler T","year":"2013","journal-title":"Clin Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0190-9622(00)90132-4","article-title":"Erythromycin in pityriasis rosea: a double-blind, placebo-controlled clinical trial","volume":"42","author":"Sharma PK","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archderm.136.6.775","article-title":"A remarkable result of a double-masked, placebo-controlled trial of erythromycin in the treatment of pityriasis rosea","volume":"136","author":"Bigby M","year":"2000","journal-title":"Arch Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000430809","article-title":"Unusual eruptions associated with Mycoplasma pneumoniae respiratory infections: review of the literature","volume":"231","author":"Terraneo L","year":"2015","journal-title":"Dermatology"},{"key":"ref35","first-page":"170","article-title":"Prospective case-control study of chlamydia, legionella and mycoplasma infections in patients with pityriasis rosea","volume":"12","author":"Chuh AA","year":"2002","journal-title":"Eur J Dermatol"},{"key":"ref36","first-page":"35","article-title":"Oral erythromycin is ineffective in the treatment of pityriasis rosea","volume":"7","author":"Rasi A","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0378-6323.125484","article-title":"The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial","volume":"80","author":"Pandhi D","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref38","first-page":"802","article-title":"Efficacy of clarithromycin in pityriasis rosea","volume":"24","author":"Ahmed N","year":"2014","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0378-6323.148572","article-title":"The efficacy of macrolides and acyclovir in pityriasis rosea","volume":"81","author":"Drago F","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.4103\/2229-5178.164480","article-title":"Narrowband UVB phototherapy in pityriasis rosea","volume":"6","author":"Jairath V","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5021\/ad.2009.21.3.230","article-title":"Low-dose ultraviolet A1 phototherapy for treating pityriasis rosea","volume":"21","author":"Lim SH","year":"2009","journal-title":"Ann Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1468-3083.2004.00803.x","article-title":"UVB phototherapy for pityriasis rosea","volume":"18","author":"Valkova S","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0190-9622(95)90293-7","article-title":"UVB phototherapy for pityriasis rosea: a bilateral comparison study","volume":"33","author":"Leenutaphong V","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000363568","article-title":"Relapsing pityriasis rosea","volume":"229","author":"Drago F","year":"2014","journal-title":"Dermatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000381285","article-title":"Pityriasis rosea in children: clinical features and laboratory investigations","volume":"231","author":"Drago F","year":"2015","journal-title":"Dermatology"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010684.pub2","article-title":"Interventions for men and women with their first episode of genital herpes","author":"Heslop R","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref47","first-page":"375","article-title":"Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: systematic review and meta-analysis","volume":"8","author":"Rojas-Mirquez JC","year":"2014","journal-title":"Front Behav Neurosci"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v93n5\/0365-0596-abd-93-05-0686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:45Z","timestamp":1747666845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962018000500686&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["S0365-05962018000500686"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20187252","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}